| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |